Skip to main content
logo
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.180
+0.020 (0.48%)
Sep 17, 2026, 4:00 PM EDT - Market closed

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
343725218358--
Market Cap Growth
21.90%233.00%-39.13%---
Enterprise Value
13861071523--
Last Close Price
4.189.936.5813.42--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.402.941.863.15--
P/TBV Ratio
1.462.941.863.15--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.090.100.19-
Net Debt / Equity Ratio
-0.87-0.70-0.95-0.97-0.89-1.05
Net Debt / EBITDA Ratio
2.171.601.061.621.062.68
Net Debt / FCF Ratio
2.311.761.371.841.163.06
Asset Turnover
----0.010.02
Quick Ratio
13.5710.815.327.055.3918.24
Current Ratio
13.8911.215.527.215.5818.35
Return on Equity (ROE)
-46.76%-55.00%-85.37%-71.54%-58.84%-65.27%
Return on Assets (ROA)
-27.59%-32.86%-46.11%-36.15%-32.33%-38.07%
Return on Capital Employed (ROCE)
-39.80%-43.40%-85.20%-55.90%-73.10%-39.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-25.45%-13.79%-45.18%-18.57%--
FCF Yield
-25.86%-13.65%-37.51%-16.67%--
Buyback Yield / Dilution
-113.19%-68.76%-493.67%-228.42%-5.00%-7.72%
SEC Filings: 10-K · 10-Q